TIDMEDX 
 
LONDON: March 1, 2023 
 
                             EDX Medical Group Plc 
 
                       ("EDX Medical" or the "Company") 
 
                       Total Voting Rights - Correction 
 
In accordance with the Financial Conduct Authority's Disclosure and 
Transparency Rules, the Company hereby announces that it has 252,500,000 
ordinary shares of 1 pence each ("Ordinary Shares") in issue, each share 
carrying the right to one vote. 
 
The above figure of 252,500,000 Ordinary Shares may be used by shareholders in 
the Company as the denominator for the calculations by which they will 
determine if they are required to notify their interest in, or a change to 
their interest in, the share capital of the Company under the Financial Conduct 
Authority's Disclosure and Transparency Rules. 
 
The above figure reflects the Ordinary Shares issued in connection with the 
acquisition of Torax Biosciences Ltd, announced on February 17, 2023, and 
corrects the Total Voting Rights figure set out in that announcement. 
 
The directors of the Company accept responsibility for the contents of this 
announcement. 
 
For more information, please contact: 
 
EDX Medical PLC 
Mike Hudson 
Tel: 07812345301 
 
Peterhouse: 
Guy Miller 
Tel: 020 7220 9795 
 
Media House International, 
Ramsay Smith 
Tel:   +44 (0) 7788 414856: 
 
email: ramsay@mediahouse.co.uk 
 
 
 
END

(END) Dow Jones Newswires

March 01, 2023 06:33 ET (11:33 GMT)

EDX Medical (AQSE:EDX)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024 Click aqui para mais gráficos EDX Medical.
EDX Medical (AQSE:EDX)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024 Click aqui para mais gráficos EDX Medical.